Delivery Order SPE2DB24D2205-SPE2DB25FEFUV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.75ML) under a firm fixed-price contract valued at $21,916.13. The order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $8,825.82 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Viscoat Syringes in 0.5ml quantities. The delivery order, which closes on July 24, 2025, represents a competitively awarded contract with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,168.21 to AmerisourceBergen Drug Corp for the supply of Viscoat Syringes in 0.5 mL quantities. This firm fixed price, non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a delivery order, this award falls under a larger contract vehicle that enables AmerisourceBergen to supply pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,066.90 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes in 0.5ML configuration. This competitive, non-set-aside contract operates under a firm fixed price structure with an ultimate completion date of July 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued as a child contract under...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.5 mL VISCOAT syringes. The $5,065.40 firm-fixed-price contract has a completion date of May 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
- This $21,290.28 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.5 mL VISCOAT syringes. The order has an ultimate completion date of August 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities supporting...
- The Defense Logistics Agency Troop Support Medical awarded a $20,038.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for VISCOAT SYRINGE 0.5ML. The delivery order was issued against an undisclosed government-wide acquisition contract vehicle or blanket purchase agreement held by Amerisourcebergen. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required by August 28, 2023. No subcontractors or set aside designations were...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,141.35, is for the delivery of 0.5 milliliter Viscoat syringes. The contract is a firm fixed-price delivery order, with a completion date of January 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $7,238.88 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of "VISCOAT SYRINGE 0.5ML", a medical supply product, with a completion date of July 11, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a $7,001.06 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide 0.5 mL VISCOAT syringes. This delivery order was issued under an existing $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor, which serves as the primary vehicle for the company to supply...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFUVDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Viscoat Syringes (0.5 mL), valued at $3,087.53. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor, particularly for Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio with DLA demonstrates its capability to fulfill diverse medical supply requirements through competitive procurement, ranging from small-value transactions to substantial orders. This specific delivery order for medical syringes reflects the company's ongoing role in supplying essential medical commodities and devices that support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/4/25 |